POMALYT CAPSULES*
- Pomalidomide -(Pomalyst)- @- (Feb 2013) Chemotherapeutic Agents
Compositions:
Pomalidomide -mg capsules,
List of Related Indications:
Pomalidomide -mg capsules,
- Multiple Myleloma Patients who have received at least two prior therapies, including Lenalidomide and Bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy
Strength | Rate | Packing Style |
---|---|---|
mg | 0.00 | unit capsules |